Clinical TrialsSearch results
Number of results: 693
Recruiting
- A study of neural mechanism of non-invasive brain stimulation combined rehabilitation training.
- Neurological diseases
- Mukaino Masahiko
- 2020-12-21
Recruiting
- A Study of TAK-341 in Treatment of Multiple System Atrophy
- Multiple System Atrophy
- Nonomura Hidenori
- 2022-12-20
Recruiting
- A Study to Assess Treat-to-Target and Dosing Flexibility of Oral Upadacitinib Tablets in Adult Participants With Moderate to Severe Atopic Dermatitis
- Atopic Dermatitis
- Yamazaki Hayato
- 2023-07-20
Recruiting
- A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Any Known or Suspected Problems of the Body (Except Brain or Spinal Cord-related Problems) (Quanti OBR)
- Adults with known or suspected pathology of any body region (except CNS)
- Myoishi Masafumi
- 2023-07-28
Recruiting
- A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Known or Suspected Brain or Spinal Cord-related Problems (Quanti CNS)
- Adults with known or suspected pathology of the central nervous system (CNS)
- Myoishi Masafumi
- 2023-07-28
Recruiting
- A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants with Moderate to Severe Atopic Dermatitis
- Atopic Dermatitis
- Yamazaki Hayato
- 2023-04-10
Recruiting
- A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Participants With Thyroid Eye Disease
- thyroid eye disease(TED)
- Giulio Barteselli
- 2023-09-29
Recruiting
- A STUDY TO EVALUATE THE EFFICACY, SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF SATRALIZUMAB IN PATIENTS WITH NMDAR OR LGI1ENCEPHALITIS
- Autoimmune Encephalitis
- James Overell
- 2022-08-26
Recruiting
- A Study to Learn How Gadoquatrane Moves Into, Through, and Out of the Body and How Safe it is in Children (From Birth to <18 Years), Who Will Undergo a Contrast Enhanced MRI (Quanti Pediatric)
- pediatric participants (from birth to <18 years) undergoing contrast-enhanced MRI
- Myoishi Masafumi
- 2023-07-28
Recruiting
- AB122 Platform study
- Advanced or metastatic solid tumor
- Nasermoaddeli Ali
- 2021-07-27